Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > I wonder if ...

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Jul 20, 2021 3:41pm

153 Views

Post# 33576451

RE:RE:I wonder if ...

Yeah, I have a tip for brain surgeons. "Get gebremeskel as a patient. He's stupid AF and needs a lot of work. You'll make a fortune."
I was the one who proposed to Dr. Mandel that the pre-treatment scraping in the first three patients of Ph1 could be the cause of the cancer's appearance in their ureters. So, they stopped scraping for the next three, and voila! Two CR's out of three!
GoJo - 1 gebremeskel - a big, fat zero

gebremeskel wrote: gojotv! - While you're at it, do you have any tips for brain surgeons? Perhaps they could also benefit from your expertise.

gojotv! wrote: ...we'd see a better result if the patients held in the formula a little longer.
Maybe it takes more time for cancer cells that have been treated with BCG to absorb the TLD-1433.
Another 15-20 minutes would be uncomfortable for the patients, but could be the tipping point that make all the difference.
And what about throat cancers? It would be easy to treat them using the same modality as bladder cancer... just gargle and go... providing TLD-1433 doesn't taste too bad...
Anyway, there's a long road of trials ahead, and right now, we're well ahead of competitors. The future is looking bright!